High FAP expression is correlated with a poor outcome in multiple solid cancers, and together its prominent expression in > 90% of epithelial carcinomas and its tumor-promoting role, make FAP a promising target for anti-cancer interventions [1–3]. The gene discussed is FAP; the disease is carcinoma.